Dashboard E. coli
Repurposing candidates for E. coli
Escherichia coli
Approved medicines with AI-predicted activity ≥40% against E. coli, leaving out medicines that are already antimicrobials. Each is shown with what it is already used for. They are surfaced computationally for further investigation, not as treatments.
- AI-predicted activity ≥40%
- 467
- Existing antimicrobials set aside
- 103
- Needing review
- 28
- Repurposing candidates
- 336
Repurposing candidates for E. coli
AI prediction · nothing measuredAll 336 repurposing candidates for E. coli.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- EzetimibeExisting use: Cardiovascular disease, Familial hypercholesterolemia, Homozygous familial hypercholesterolemia and 2 more43.1% AI-predicted activityagainst E. coli50+ registered studies
- ThiothixeneExisting use: Psychosis, Schizophrenia43.1% AI-predicted activityagainst E. coli5 registered studies
- Bazedoxifene AcetateExisting use: Postmenopausal osteoporosis43.1% AI-predicted activityagainst E. coli50+ registered studies
- Topotecan HydrochlorideExisting use: Carcinoma, Cervical adenocarcinoma, Cervical cancer and 5 more43.1% AI-predicted activityagainst E. coli50+ registered studies
- CabergolineExisting use: Hypothalamic neoplasm, Parkinson disease43.0% AI-predicted activityagainst E. coli50+ registered studies
- DroperidolExisting use: Nausea and vomiting, Post operative nausea and vomiting, Psychosis43.0% AI-predicted activityagainst E. coli42 registered studies
- LemborexantExisting use: Insomnia43.0% AI-predicted activityagainst E. coli50+ registered studies
- Osimertinib MesylateExisting use: Cancer, Neoplasm, Non-small cell lung carcinoma43.0% AI-predicted activityagainst E. coli26 registered studies
- Pyrilamine MaleateExisting use: Allergic disease, Pruritus, Seasonal allergic rhinitis43.0% AI-predicted activityagainst E. coli1 registered study
- Alogliptin BenzoateExisting use: Type 2 diabetes mellitus42.9% AI-predicted activityagainst E. coli10 registered studies
- Lurasidone HydrochlorideExisting use: Bipolar disorder, Bipolar I disorder, Schizophrenia42.8% AI-predicted activityagainst E. coli50+ registered studies
- Elacestrant HydrochlorideExisting use: Breast neoplasm, Male breast carcinoma42.8% AI-predicted activityagainst E. coli2 registered studies
- Ritlecitinib TosylateExisting use: Alopecia areata42.8% AI-predicted activityagainst E. coli1 registered study
- NifurtimoxExisting use: American trypanosomiasis, Chagas disease, Leishmaniasis and 1 more42.7% AI-predicted activityagainst E. coli19 registered studies
- AprepitantExisting use: Cancer, Chemotherapy-induced nausea and vomiting, Nausea and 3 more42.7% AI-predicted activityagainst E. coli50+ registered studies
- Piflufolastat F-18Existing use: Computed tomography, Metastatic prostate cancer, Prostate adenocarcinoma and 2 more42.7% AI-predicted activityagainst E. coli50+ registered studies
- RisdiplamExisting use: Atrophy, Proximal spinal muscular atrophy, Spinal muscular atrophy42.7% AI-predicted activityagainst E. coli33 registered studies
- Olmesartan MedoxomilExisting use: Cardiovascular disease, Diabetes mellitus, Heart failure and 3 more42.6% AI-predicted activityagainst E. coli50+ registered studies
- Fosinopril SodiumExisting use: Cardiovascular disease, Heart failure, Hypertension42.6% AI-predicted activityagainst E. coli21 registered studies
- MavorixaforExisting use: Neoplasm42.5% AI-predicted activityagainst E. coli15 registered studies
- MifepristoneExisting use: Cushing syndrome42.4% AI-predicted activityagainst E. coli50+ registered studies
- NatamycinExisting use: Eye infection, Infection42.4% AI-predicted activityagainst E. coli15 registered studies
- Sildenafil CitrateExisting use: Connective tissue disease, Erectile dysfunction, Idiopathic and/or familial pulmonary arterial hypertension and 3 more42.4% AI-predicted activityagainst E. coli50+ registered studies
- RemdesivirExisting use: Coronavirus infectious disease, Covid-19, Severe acute respiratory syndrome and 1 more42.3% AI-predicted activityagainst E. coli50+ registered studies